0

Over-the-Counter Drug Market 2016-2020

  • Published: Aug 2016
  • Pages: 120
  • SKU: IRTNTR10079
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

This market research report analyzes the key players in the OTC drug market such as Bayer HealthCare, GSK, Johnson & Johnson, Pfizer, and Sanofi. The report also presents a competitive analysis of the market by therapeutic class (dietary supplements, gastrointestinal drugs, pain medications, respiratory drugs, and others), by route of administration (oral, topical, parenteral, and others), and by geography (the Americas, APAC, and EMEA).

Global  over-the-counter (OTC) drugs market forecast

Technavio’s market research analysts have predicted that the global OTC drug market will grow impressively during the predicted period and will post a revenue of about USD 162 billion by 2020. This industry research report identifies the lenient regulatory framework and the availability of several distribution channels to be the major driver for the over the counter drug market growth in the coming years. Also, the increasing healthcare costs will result in patients opting for over the counter drugs rather than consulting physicians. The rise in the number of pharmaceutical retail stores and shift in the focus of pharmaceutical companies towards targeting hypermarkets, supermarkets, and grocery stores as distribution channels for their drugs will also increase the over the counter drug market size.

This market study estimates that in terms of geography, the Americas will continue to dominate the market during the forecast period and will account for almost 38% of the total revenue shares. The increased consumption and sales of OTC gastrointestinal drugs and the rise in the preference for non-prescription drugs over prescription drugs in Latin American countries such as Brazil and Mexico will drive the growth of the market in this region. Additionally, the rising awareness about health and well-being, proactive healthcare practices, and the concern over growing healthcare costs will also fuel the growth of the OTC medicine market in the Americas.

Competitive landscape and key vendors

Characterized by the presence of several well-established vendors and small-scale regional OTC manufacturers, this market appears to be highly fragmented. The market is currently dominated by major players such as Bayer HealthCare, GSK, Johnson & Johnson, Pfizer, and Sanofi who account for more than 15% of the total revenue shares. To expand their product portfolio and their geographical presence, leading vendors have started acquiring small regional vendors. The coming years will witness an increase in M&A activities, the introduction of new over the counter medicines, and strategic expansions, which will intensify the competition among vendors.

The leading vendors in the market are

  • Bayer HealthCare
  • GSK
  • Johnson & Johnson
  • Pfizer
  • Sanofi

The other prominent vendors in the market are Abbott, Achelios Therapeutics, American Health, Amgen, Arena Pharmaceuticals, AstraZeneca, BioGaia, Bristol-Myers Squibb, Bukwang Pharmaceutica, Chr. Hansen, Cipla, CoLucid, Daiichi Sankyo, Dr. Reddy's Laboratories, DSM, Eisai, Eli Lilly, EMS-SA, Euradite, Friggs, Pharmaceuticals, Teva Pharmaceuticals, UCB, Unifarma Global Consumer healthcare, Valeant, and Vida Laboratories.

Segmentation by therapeutic class and analysis of the OTC drug market

  • Dietary supplements
  • Gastrointestinal drugs
  • Pain medications
  • Respiratory drugs

During 2015, the respiratory drugs market segment accounted for about 34% of the total shares of the over the counter medication market and dominated the industry. This mainly attributes to the rising incidences of allergies, cold, and flu due to seasonal changes. Analysts estimate that this segment will show a steady growth during the forecast period at a CAGR of more than 5%.

Segmentation by route of administration and analysis of the OTC drug market

  • Oral
  • Topical
  • Parenteral

Accounting for about 60% of the total shares of the market, the oral medications market segment dominated the over the counter products market during 2015. This is a sub-division of enteral administration and drugs administered through this route undergo the first-pass metabolism. It is considered one of the safest and most preferred routes of drug administration and can be administered as tablets, capsules, and oral liquids.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2020?
  • What are the key factors driving the global OTC drug market?
  • What are the key market trends impacting the growth of the global OTC drug market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global OTC drug market?
  • What are the market opportunities and threats faced by the vendors in the global OTC drug market?
  • Trending factors influencing the market shares of the Americas, APAC, and EMEA.
  • What are the key outcomes of the five forces analysis of the global OTC drug market?

Technavio also offers customization on reports based on specific client requirement.

Related reports

Read More Read Less

 

Table of Content

PART 01: Executive summary

  • Highlights

PART 02: Scope of  the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: OTC drugs: An overview

  • Regulatory pathways for OTC approval
  • FDA OTC drug approval process
  • Strategies to penetrate OTC pharmaceuticals in emerging markets

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Market segmentation by therapeutic class

PART 08: Global respiratory OTC drugs market

  • Market overview

PART 09: Global dietary supplements market

  • Market overview

PART 10: Global gastrointestinal OTC drugs market

  • Market overview
  • Market segmentation by therapeutic class of drug

PART 11: Global OTC pain medications market

  • Market overview
  • Market segmentation by therapeutic class of drug

PART 12: Market segmentation by route of administration

  • Oral
  • Topical
  • Parenteral

PART 13: Geographical segmentation

  • Global OTC drugs market by geography 2015-2020
  • OTC drugs market in Americas
  • OTC drugs market in US
  • OTC drugs market in EMEA
  • OTC drugs market in Germany
  • OTC drugs market in France
  • OTC drugs market in APAC
  • OTC drugs market in China
  • OTC drugs market in Japan
  • OTC drugs market in India

PART 14: Market drivers

  • Switching of medications from prescription to OTC
  • Lenient regulatory framework and distribution channel
  • Cost-effective OTC drugs
  • Rise in self-medication

PART 15: Impact of drivers

PART 16: Market challenges

  • Counterfeit drugs
  • Lack of valid literature
  • High expenditure on advertisements

PART 17: Impact of drivers and challenges

PART 18: Market trends

  • Accelerated use of online resources
  • Promotions and marketing initiatives
  • Strategic alliances

PART 19: Vendor landscape

  • Competitive scenario

PART 20: Key vendor analysis

  • GSK
  • Johnson & Johnson
  • Pfizer
  • Bayer HealthCare
  • Sanofi3
  • Other prominent vendors

PART 21: Appendix6

  • List of abbreviations

PART 22: Explore Technavio

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Report
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>